Literature DB >> 6941378

Muscarinic receptors in the stomach.

R Hammer.   

Abstract

Using tritiated N-methyl-scopolamine (3H-NMS), muscarinic receptor binding was demonstrated in broken cell preparation of mucosa and smooth muscle of the fundus of the canine stomach. Binding curves of pirenzepine were established in competition experiments against 3H-NMS. Pirenzepine shows a considerably higher affinity to muscarinic receptors from fundic mucosa than those from smooth muscle, suggesting a difference of muscarinic receptors in these two regions of the stomach. Different properties of mucosal and smooth muscle receptors could be further substantiated by agonist binding studies. Whilst carbachol binding to muscarinic receptors from fundic smooth muscle was modulated by guanine nucleotides, no such effect was found in fundic mucosa. Direct binding studies with 3H-NMS demonstrated muscarinic receptors in peripheral ganglia (sympathetic trunk ganglia from the calf, stellate ganglia from the dog). These are characterized by high affinity pirenzepine binding so that besides its direct action on gastric secretory glands, pirenzepine may influence indirectly gastrointestinal functions via peripheral, presumably intramural, ganglia.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6941378

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  13 in total

1.  Comparison of the kinetics and extent of muscarinic M1-M5 receptor internalization, recycling and downregulation in Chinese hamster ovary cells.

Authors:  Arunkumar Thangaraju; Gregory W Sawyer
Journal:  Eur J Pharmacol       Date:  2010-10-31       Impact factor: 4.432

2.  Effect of cimetidine and pirenzepine in combination on 24 hour intragastric acidity in subjects with previous duodenal ulceration.

Authors:  J G Williams; M Deakin; J K Ramage
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

3.  Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man.

Authors:  V Coiro; P Chiodera; R Volpi; L d'Amato; L Camellini; G Rossi; D Pignatti; U Butturini
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

4.  Dose-dependent heart rate reducing effect of nizatidine, a histamine H2-receptor antagonist.

Authors:  H Hinrichsen; A Halabi; G Fuhrmann; W Kirch
Journal:  Br J Clin Pharmacol       Date:  1993-05       Impact factor: 4.335

5.  Human gastric mucosa expresses glandular M3 subtype of muscarinic receptors.

Authors:  A Pfeiffer; C Hanack; R Kopp; R Tacke; U Moser; E Mutschler; G Lambrecht; M Herawi
Journal:  Dig Dis Sci       Date:  1990-12       Impact factor: 3.199

6.  Suppression of myoelectrical activity of gastric smooth muscle by endogenous gastric prostaglandin E2.

Authors:  K Nishiyama; M Katori; A Ueno; T Ohno; K Saigenji
Journal:  Dig Dis Sci       Date:  1992-07       Impact factor: 3.199

7.  Mechanisms mediating cholinergic antral circular smooth muscle contraction in rats.

Authors:  Helena-F Wrzos; Tarun Tandon; Ann Ouyang
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Effects of H2-receptor antagonists and anticholinoceptor drugs on gastric and salivary secretion induced by bethanechol in the anaesthetized dog.

Authors:  M J Daly; J M Humphray; R Stables
Journal:  Br J Pharmacol       Date:  1982-07       Impact factor: 8.739

9.  Possible mechanisms of anti-cholinergic drug-induced bradycardia.

Authors:  E C Meyer; D K Sommers
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

10.  Selectivity of oxomemazine for the M1 muscarinic receptors.

Authors:  S W Lee; C W Woo; J G Kim
Journal:  Arch Pharm Res       Date:  1994-12       Impact factor: 4.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.